Page last updated: 2024-08-23
enoximone and fluo-3
enoximone has been researched along with fluo-3 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bednarik, DP; Houser, SR; Jung, AS; Margulies, KB; Mills, GD; Quaile, MP | 1 |
Other Studies
1 other study(ies) available for enoximone and fluo-3
| Article | Year |
|---|---|
Pharmacological effects of ATI22-107 [2-(2-{2-[2-chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester)], a novel dual pharmacophore, o
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aniline Compounds; Animals; Calcium; Calcium Channels, L-Type; Calcium Signaling; Cardiotonic Agents; Cats; Cell Separation; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Enoximone; Fluorescent Dyes; In Vitro Techniques; Myocardial Contraction; Myocytes, Cardiac; Nifedipine; Phosphodiesterase Inhibitors; Xanthenes | 2005 |